ARL offers a full range of professional laboratory services including; potency, sterility, endotoxin, compendial testing, as well as consulting services, research and development and forensic legal support.
Emerson Resources provides pre-formulation through phase III and small commercial production. They have been producing phase I and II clinical supplies since 2005 and will be adding phase III and small volume and orphan drug commercial manufacturing in 2013.
Glomics, Inc. targets global genomics technologies, develops microarray-based technologies and provides their associated services to customers working in a variety of fields involved in microbial functional genomics, community genomics, microbial ecology, environmental microbiology, and geobiochemistry.
Haus Bioceuticals is developing safe and effective products, including Metaderm. Metaderm resolves eczema through a vast combination of spagyric essenses formulated specifically to address the immune signaling disregulation associated with atopic dermatitis and eczema.
Inoveon is a premier medical services company that delivers solutions to detect, stage and monitor diseases affecting the eye – diabetic retinopathy, macular degeneration, and glaucoma. Inoveon’s initial target is to help patients and their providers improve diabetic retinopathy care through Inoveon diagnostic service centers that are co-located in high volume diabetes care sites.
Progentec Diagnostics, Inc., (?Progentec?) aims to explore and commercialize state of the art diagnostic solutions in therapeutic areas with a high level of unmet need. The company?s current project is an advanced state-of-the-art lupus flare diagnostic, which has potential to fundamentally change the current treatment paradigm for lupus.
TML performs a variety of diagnostic services, including tissue, cytology, bone marrow examinations, clinical consultations, blood bank services, peripheral blood and other body fluid smear consultations, and frozen section evaluation.